Evidence map›Paper›PMID 26698318›Full record

ArticleJournal of bioenergetics and biomembranes2017

MAC inhibitors antagonize the pro-apoptotic effects of tBid and disassemble Bax / Bak oligomers.

Pablo M Peixoto, Oscar Teijido, Oygul Mirzalieva, Laurent M Dejean, Evgeny V Pavlov, Bruno Antonsson, Kathleen W Kinnally

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Journal of bioenergetics and biomembranes, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Editorial note.Journal of bioenergetics and biomembranes · 2017
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Pablo M PeixotoBaruch College and Graduate Center of City University of New York (CUNY), New York, NY, 10010, USA. pablo.peixoto@baruch.cuny.edu.ORCID http://orcid.org/0000-0001-5953-6027
Oscar TeijidoEunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, 20892, USA.
Oygul MirzalievaBaruch College and Graduate Center of City University of New York (CUNY), New York, NY, 10010, USA.
Laurent M DejeanDepartment of Chemistry, California State University of Fresno, Fresno, CA, 93740, USA.
Evgeny V PavlovNew York University College of Dentistry, New York, NY, 10010, USA.
Bruno AntonssonMerck Serono, Geneva Research Center, Geneva, 1202, Switzerland.
Kathleen W KinnallyNew York University College of Dentistry, New York, NY, 10010, USA.
New York University · USThe Graduate Center, CUNY · USCalifornia State University, Fresno · USMerck Serono (Switzerland) · CHNational Institutes of Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitochondrial Apoptotic Channel inhibitors or iMACs are di-bromocarbazole derivatives with anti-apoptotic function which have been tested and validated in several mouse models of brain injury and neurodegeneration. Owing to the increased therapeutic potential of these compounds, we sought to expand our knowledge of their mechanism of action. We investigated the kinetics of MAC inhibition in mitochondria from wild type, Bak, and Bax knockout cell lines using patch clamp electrophysiology, fluorescence microscopy, ELISA, and semiquantitative western blot analyses. Our results show that iMACs work through at least two mechanisms: 1) by blocking relocation of the cytoplasmic Bax protein to mitochondria and 2) by disassembling Bax and Bak oligomers in the mitochondrial outer membrane. iMACs exert comparable effects on channel conductance of Bax or Bak and similarly affect cytochrome c release from Bax or Bak-containing mitochondria. Interestingly, wild type mitochondria were more susceptible to inhibition than the Bak or Bax knockouts. Western blot analysis showed that wild type mitochondria had lower steady state levels of Bak in the absence of apoptotic stimulation.

Indexed as

AnimalsApoptosisbcl-2-Associated X Proteinbcl-2 Homologous Antagonist-Killer ProteinBH3 Interacting Domain Death Agonist ProteinCarbazolesCell LineCytochromes cFibroblastsMiceMitochondriaProtein MultimerizationBak1 protein, mousebcl-2-Associated X Proteinbcl-2 Homologous Antagonist-Killer ProteinBH3 Interacting Domain Death Agonist ProteinCarbazolesCytochromes cApoptosisBakBaxMAC inhibitorsMOMPPatch clamptBid

Identifiers

PMID26698318
OpenAlexW2197592328

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.